Exosomes as Vehicles for Noncoding RNA in Modulating Inflammation: A Promising Regulatory Approach for Ischemic Stroke and Myocardial Infarction
Zhuhong Lai,Tingqiao Ye,Mingjun Zhang,Ying Mu
DOI: https://doi.org/10.2147/jir.s484119
IF: 4.5
2024-10-22
Journal of Inflammation Research
Abstract:Zhuhong Lai, Tingqiao Ye, Mingjun Zhang, Ying Mu Department of Cardiology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, 621000, People's Republic of China Correspondence: Ying Mu, Department of Cardiology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, 621000, People's Republic of China, Email Exosomes have grown as promising carriers for noncoding RNAs (ncRNAs) in the treatment of inflammation, particularly in conditions like ischemic stroke and myocardial infarction. These ncRNAs, which include microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), play a crucial role in regulating inflammatory pathways, presenting new therapeutic opportunities. In both ischemic stroke and myocardial infarction, inflammation significantly influences disease progression and severity. Exosomes can deliver ncRNAs directly to specific cells and tissues, providing a targeted approach to modulate gene expression and reduce inflammation. Their biocompatibility and low risk of inducing immune responses make exosomes ideal therapeutic vehicles. Ongoing research is focused on optimizing the loading of ncRNAs into exosomes, ensuring efficient delivery, and understanding the mechanisms by which these ncRNAs mitigate inflammation. In ischemic stroke, exosome-derived ncRNAs originate from various cell types, including neurons, M2 microglia, patient serum, genetically engineered HEK293T cells, and mesenchymal stromal cells. In the case of myocardial infarction, these ncRNAs are sourced from mesenchymal stem cells, endothelial cells, and patient plasma. These exosome-loaded ncRNAs play a significant role in modulating inflammation in both ischemic stroke and myocardial infarction. As this research advances, therapies based on exosomes may completely change how diseases linked to inflammation are treated, offering new avenues for patient care and recovery. This review explores the latest advancements in understanding how exosomes impact specific inflammatory components, with a particular emphasis on the role of ncRNAs contained in exosomes. The review concludes by highlighting the clinical potential of exosome-derived ncRNAs as innovative therapeutic and diagnostic tools. Keywords: exosomes, noncoding RNA, inflammation, ischemic stroke, myocardial infarction Both myocardial infarction and ischemic stroke cause the release of pro-inflammatory cytokines, chemokines, and other mediators, which are indicative of a systemic inflammatory response. 1,2 This inflammation not only contributes to the initial injury but also exacerbates damage in the brain and heart. 1,2 The inflammatory responses in these conditions are interconnected, with each condition capable of intensifying the other's inflammatory reaction. 3 For example, an ischemic stroke can heighten systemic inflammation, potentially worsening myocardial infarction outcomes by increasing cardiac stress and injury. Conversely, a myocardial infarction can boost systemic inflammation, potentially aggravating brain injury and hindering recovery following a stroke. This bidirectional relationship underscores the interconnected nature of inflammation in these two conditions, where the inflammatory processes in one can exacerbate the severity and complications of the other. 3,4 Despite the clear pathophysiological distinctions among stroke and myocardial infarction, their gene responses to injury show significant similarities. 1,5 These commonalities extend to both protein-coding RNAs and non-coding RNAs (ncRNAs). 1,5 Recent studies highlight the critical role of ncRNAs produced by exosomes in regulating cell-to-cell communication within shared signaling pathways. 1 These ncRNAs have garnered significant attention for their role in modulating inflammation in both ischemic stroke and myocardial infarction. 6–10 Of note, ncRNAs are selectively concentrated within exosomes, 11 and these transferred ncRNAs play a crucial role in regulating various aspects of the initiation and progression of injuries in both the brain and heart. The shared inflammatory pathways and responses in these cardiovascular and cerebrovascular events emphasize their interconnected nature, with emerging data suggesting that ncRNAs from exosomes are key regulators of inflammation in these pathologies. 1 The modulation of ischemic stroke and myocardial infarction pathophysiology by ncRNAs from exosomes is well-documented. 12–15 Extensive research has demonstrated the role of exosome-ncRNAs in regulating inflammation in both conditions. 16–18 This review aims to summarize the latest advancements in studying exosome-ncRNAs regarding ischemic stroke and myocardial infar -Abstract Truncated-
immunology